Who invested in CRISPR THERAPEUTICS?
CRISPR THERAPEUTICS's investors include New Enterprise Associates, Versant Ventures and Franklin Templeton.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$550Mraised across 1 round since 2026, from 1 source
From CRISPR THERAPEUTICS's own website: 3 on the team.
CRISPR THERAPEUTICS's investors include New Enterprise Associates, Versant Ventures and Franklin Templeton.
CRISPR THERAPEUTICS has raised $550M across 1 round since 2026.
CRISPR THERAPEUTICS's most recent round was a Debt of $550M in Mar 2026.
Its most recent round, $550M in Mar 2026, is also its largest on record.
CRISPR THERAPEUTICS's first round on record, in Mar 2026, was backed by New Enterprise Associates, Versant Ventures and Franklin Templeton.
CRISPR THERAPEUTICS's latest named round is a Debt, in Mar 2026.
CRISPR THERAPEUTICS is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.